Takeuchi Muneyuki, Tachibana Kazuya
Department of Intensive Care Medicine, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodocho, Izumi, Osaka, 594-1101, Japan.
Cardiovasc Hematol Disord Drug Targets. 2015;15(1):41-5. doi: 10.2174/1871529x15666150108113853.
The mortality rate among patients suffering acute respiratory distress syndrome (ARDS) remains high despite implementation at clinical centers of the lung protective ventilatory strategies recommended by the International Guidelines for Management of Severe Sepsis and Septic Shock, 2012. This suggests that such strategies are still sub-optimal for some ARDS patients. For these patients, tailored use of ventilator settings should be considered, including: further reduction of tidal volumes, administration of neuromuscular blocking agents if the patient's spontaneous breathing is incompatible with mechanical ventilation, and adjusting positive end-expiratory pressure (PEEP) settings based on transpulmonary pressure levels.
尽管临床中心已实施了《2012年严重脓毒症和脓毒性休克治疗国际指南》推荐的肺保护性通气策略,但急性呼吸窘迫综合征(ARDS)患者的死亡率仍然很高。这表明,对于某些ARDS患者来说,这些策略仍未达到最佳效果。对于这些患者,应考虑量身定制呼吸机设置,包括:进一步降低潮气量;如果患者的自主呼吸与机械通气不兼容,则给予神经肌肉阻滞剂;并根据跨肺压水平调整呼气末正压(PEEP)设置。